Primary cutaneous cryptococcosis: A distinct clinical entity

被引:152
|
作者
Neuville, S
Dromer, F
Morin, O
Dupont, B
Ronin, O
Lortholary, O
机构
[1] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycoses & Antifong, F-75724 Paris 15, France
[2] Hop Necker Enfants Malad, Serv Malad Infect & Trop, Paris, France
[3] Hop Hotel Dieu, Lab Parasitol Mycol, Nantes, France
[4] Hop Avicenne, Serv Malad Infect & Trop, F-93009 Bobigny, France
关键词
D O I
10.1086/345956
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cryptococcus neoformans is an encapsulated yeast responsible for disseminated meningitis in immunocompromised hosts. Controversies persist on the existence of primary cutaneous cryptococcosis (PCC) versus cutaneous cryptococcosis being only secondary to hematogenous dissemination. Thus, we reviewed cryptococcosis cases associated with skin lesions reported in the French National Registry. Patients with PCC (n = 28) differed significantly from those with secondary cutaneous cryptococcosis (n = 80) or other forms of the disease (n = 1866) by living area (mostly rural), age (older), ratio of men to women (similar to1: 1), and the lack of underlying disease. Evidence of PCC included the absence of dissemination and, predominantly, a solitary skin lesion on unclothed areas presenting as a whitlow or phlegmon, a history of skin injury, participation in outdoor activities, or exposure to bird droppings, and isolation of C. neoformans serotype D. Therefore, PCC is a distinct epidemiological and clinical entity with a favorable prognosis even for immunocompromised hosts.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 50 条
  • [41] Arthrofibrosis following primary total hip arthroplasty: a distinct clinical entity
    Thorsten Gehrke
    Lara Althaus
    Philip Linke
    Jochen Salber
    Veit Krenn
    Mustafa Citak
    Archives of Orthopaedic and Trauma Surgery, 2022, 142 : 511 - 515
  • [42] Primary adrenal lymphoma associated with adrenal insufficiency: A distinct clinical entity
    Pimentel, M
    Johnston, JB
    Allan, DR
    Greenberg, H
    Bernstein, CN
    LEUKEMIA & LYMPHOMA, 1997, 24 (3-4) : 363 - 367
  • [43] Subtyping primary insomnia: is sleep state misperception a distinct clinical entity?
    Edinger, JD
    Krystal, AD
    SLEEP MEDICINE REVIEWS, 2003, 7 (03) : 203 - 214
  • [44] Sjogren's syndrome and localized nodular cutaneous amyloidosis: Coincidence or a distinct clinical entity?
    Meijer, J. M.
    Schonland, S. O.
    Palladini, G.
    Merlini, G.
    Hegenbart, U.
    Ciocca, O.
    Perfetti, V.
    Leijsma, M. K.
    Bootsma, H.
    Hazenberg, B. P. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 472 - 473
  • [45] Sjogren's syndrome and localized nodular cutaneous amyloidosis - Coincidence or a distinct clinical entity?
    Meijer, Jiska M.
    Schonland, Stefan O.
    Palladini, Giovanni
    Merlini, Giampaolo
    Hegenbart, Ute
    Ciocca, Olga
    Perfetti, Vittorio
    Leijsma, Martha K.
    Bootsma, Hendrika
    Hazenberg, Bouke P. C.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (07): : 1992 - 1999
  • [46] Predescemetocele: A distinct clinical entity
    Narang, Priya
    Agarwal, Amar
    Kumar, Dhivya Ashok
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2017, 65 (11) : 1224 - +
  • [47] Primary cutaneous cryptococcosis in an immunocompetent man: A case report
    Lu, Ying-Yi
    Wu, Chieh-Shan
    Hong, Chien-Hui
    DERMATOLOGICA SINICA, 2013, 31 (02) : 90 - 93
  • [48] Primary Cutaneous Cryptococcosis in an Immunocompetent Iraq War Veteran
    Twede, James, V
    Peters, Kristopher M.
    CUTIS, 2018, 102 (05): : E30 - E31
  • [49] PRIMARY CUTANEOUS CRYPTOCOCCOSIS - SEROIMMUNOLOGIC AND FLUORESCENT ANTIBODY STUDIES
    HURWICH, BJ
    DOMONKOS, AN
    NEW YORK STATE JOURNAL OF MEDICINE, 1970, 70 (09) : 1075 - +
  • [50] Primary cutaneous follicular lymphoma - A clinicopathologic and molecular study of 16 cases in support of a distinct entity
    Goodlad, JR
    Krajewski, AS
    Batstone, PJ
    McKay, P
    White, JM
    Benton, EC
    Kavanagh, GM
    Lucraft, HH
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (06) : 733 - 741